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Abstract
Influenza A virus NS1 protein is a multifunctional virulence factor consisting of an RNA binding domain (RBD), a short linker,
an effector domain (ED), and a C-terminal ‘tail’. Although poorly understood, NS1 multimerization may autoregulate its
actions. While RBD dimerization seems functionally conserved, two possible apo ED dimers have been proposed (helix-helix
and strand-strand). Here, we analyze all available RBD, ED, and full-length NS1 structures, including four novel crystal
structures obtained using EDs from divergent human and avian viruses, as well as two forms of a monomeric ED mutant.
The data reveal the helix-helix interface as the only strictly conserved ED homodimeric contact. Furthermore, a mutant NS1
unable to form the helix-helix dimer is compromised in its ability to bind dsRNA efficiently, implying that ED multimerization
influences RBD activity. Our bioinformatical work also suggests that the helix-helix interface is variable and transient,
thereby allowing two ED monomers to twist relative to one another and possibly separate. In this regard, we found a mAb
that recognizes NS1 via a residue completely buried within the ED helix-helix interface, and which may help highlight
potential different conformational populations of NS1 (putatively termed ‘helix-closed’ and ‘helix-open’) in virus-infected
cells. ‘Helix-closed’ conformations appear to enhance dsRNA binding, and ‘helix-open’ conformations allow otherwise
inaccessible interactions with host factors. Our data support a new model of NS1 regulation in which the RBD remains
dimeric throughout infection, while the ED switches between several quaternary states in order to expand its functional
space. Such a concept may be applicable to other small multifunctional proteins.
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Introduction
During infection the influenza A virus NS1 protein participates
in multiple protein-RNA and protein-protein interactions to
perform a plethora of functions (reviewed in [1]). Examples
include its ability to act as a potent interferon (IFN) antagonist
(both pre- and post- transcriptionally) [2,3,4,5], its inhibition of
host antiviral enzymes [6,7], its enhancing effect on viral
translation [8], and its activation of phosphoinositide 3-kinase
(PI3K) signaling [9].
Approximately 30 cellular and viral factors have been reported to
interact either directly or indirectly with NS1, which seems surprising
given that NS1 itself is relatively short (only ,230 amino-acids).
However, protein multifunctionality may be a key feature of many
small RNA virus replication strategies given that they usually possess
a restricted coding capacity. Potential mechanisms that likely
influence the functions of NS1 include: (i) post-translational
modifications [10,11,12]; (ii) strain-specific polymorphisms
[13,14,15,16,17,18]; and (iii) spatio-temporal distribution [19,20].
As with many cellular proteins, different multimeric forms may also
be an important determinant of specific NS1 functions [21,22].
The N-terminal 73 amino-acid residues of NS1 form a
symmetrical homodimeric RNA-binding domain (RBD)
[23,24,25,26], which is connected to the central effector domain
(ED; residues 86-204) via an inter-domain linker [27]. The final
,25 residues of NS1 appear to be unstructured, and are termed
the C-terminal flexible ‘tail’ (FT) (Fig. 1A) [28]. Both the isolated
RBD and ED can homodimerize in solution [26,28,29,30], and
both contribute to functional NS1 multimerization during
infection [21,22]. Surprisingly, the recent full-length structure of
NS1 revealed that the EDs do not contribute to the overall dimer
interface, but instead flank the core dimeric RBDs, thus creating a
‘domain-swapped’ dimer (Fig. 1A) [27]. Nevertheless, within the
crystal lattice, the EDs formed homotypic contacts with neigh-
boring molecules, thereby confirming that higher-order oligomeric
forms of NS1 may occur [27].
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The isolated NS1 RBDs of several different influenza A virus
isolates all show a very high degree of structural homology and
conservation (refs. [24,26] and PDB IDs 2Z0A & 3M8A). In
particular, the mode of RBD dimerization does not vary between
strains, and is unaffected by binding double-stranded RNA
(dsRNA) [25]. In contrast, several possible ED homodimer
interfaces have been proposed based upon crystal structures
obtained using NS1 proteins from various strains. Initially, an
interface mediated by short b-sheets (strand-strand dimer; residues
88-91) of two NS1 molecules was suggested from the structure of
the NS1 ED from mouse-adapted A/Puerto Rico/8/34 (PR8)
(Fig. 1B) [29]. However, later structures of EDs from A/Duck/
Alberta/60/76 (Alb/76) [28] and A/Udorn/72 (Ud/72) [30] did
not possess this interface; instead dimerization was mediated by
homotypic interactions between the long a-helices (residues 170–
188) of each ED (helix-helix dimer; Fig. 1B). Of note, this helix-
helix interface was also present within the original PR8 ED
structure as an alternative to the strand-strand dimer, but was not
deemed relevant based on its small dimerization interface [29].
Nevertheless, mutation of W187, a residue responsible for key
reciprocal hydrophobic interactions at the helix-helix interface
(Fig. 1B), caused the isolated Alb/76 and Ud/72 EDs to behave
as monomers, thus providing direct experimental evidence that the
helix-helix ED dimer predominates in solution [28,31].
The precise multimeric state of functional NS1 in a biological
context is far from clear. Indeed, there is already circumstantial
evidence from structures of the NS1 ED in complex with different
cellular binding partners that suggests this domain cannot adopt
either strand-strand or helix-helix states when carrying out certain
functions (Fig. 1C) [32,33]. In this study we sought to assess the
relevance of different ED homodimer interfaces using both
biophysical and bioinformatical techniques. Crystallographic
uncertainties over protein-protein interfaces have often been
resolved by observing the same interface in homologous proteins
[34]. To this end, we present several new crystal structure forms of
different wild-type dimeric and rationally-designed monomeric
NS1 EDs grown under novel conditions, and confirm that the
helix-helix ED dimer represents the major dimerization interface
for this protein. We also analyze the properties of this weak,
transient interface using bioinformatics, functional biochemical
assays and a newly characterized monoclonal antibody that is
unlikely to recognize the helix-helix dimeric ED.
Results
The helix-helix dimer interface is conserved among all
NS1 ED structures
The favored dimerization interface of the NS1 ED remains
controversial. To date, the isolated EDs of four influenza A virus
strains have been examined by x-ray crystallography, giving rise to
two proposed homodimer forms: strand-strand and helix-helix
([28,29,30] and PDB ID 3M5R) (Fig. 1B). In order to examine
the possible dimerization arrangements of this domain in more
detail, EDs of the divergent mouse-adapted human influenza A
virus PR8 and avian influenza A virus Alb/76 were expressed and
purified from bacteria. Consistent with previous reports, both EDs
were dimeric in solution as determined by gel filtration (data not
shown and [28]). The purified EDs were screened for new
conditions under which crystallization may occur in addition to
those previously characterized. Four novel crystal forms were
identified (three for PR8 NS1 ED and one for Alb/76 NS1 ED)
and solved by x-ray crystallography using molecular replacement
(Table 1). Three of the ED structures contained two molecules of
NS1 in the asymmetric unit (PDB IDs 3OA9, 3O9S, and 3O9T),
whereas eight monomers were present in the other structure (PDB
ID 3O9U) (Table 2).
Comparison of these new structures with previously published
structures of the PR8 ED and Alb/76 ED indicated that in all
cases contacts are formed at the helix-helix dimer interface, either
within the asymmetric unit (3OA9, 3O9U, and 3O9S) or on a 2-
fold crystallographic axis (3O9T). In contrast, the strand-strand
dimer interface is totally absent except for 3O9U (Table 2).
Extension of these comparisons to all reported isolated NS1 ED
Figure 1. Structures of the influenza A virus NS1 protein. (A)
Full-length dimeric NS1. The RNA-binding domain (RBD), effector
domain (ED), inter-domain linker, and flexible ‘tail’ are labeled. Neither
the inter-domain linker nor the flexible ‘tail’ have been observed in
crystal structures, and are therefore represented schematically. Figure
generated using PDB ID 3F5T. (B) The two proposed NS1 ED
dimerization interfaces: strand-strand and helix-helix. W187 is
highlighted in both structures. Figure generated using PDB ID 2GX9. (C)
Incompatibilities between ED homodimerization and ED
binding cellular proteins. Shown are complexes of NS1 ED with
the p85b-iSH2 domain (left panel, PDB ID 3L4Q) and CPSF30-F2F3
domain (right panel, PDB ID 2RHK). W187 is highlighted for reference.
Note incompatibilities between NS1:p85b, the strand-strand dimer (Fig.
1B, left), and the full-length NS1 dimer (Fig. 1A). Note incompatibil-
ities between NS1:CPSF30 and the helix-helix dimer (Fig. 1B, right). In
all panels, NS1 monomers are colored green or wheat, and cellular
proteins are colored red. The N- and C- termini of NS1 constructs are
labeled. For the NS1:CPSF30 structure in Fig. 1C, right the second
monomers of NS1 ED and CPSF30-F2F3 that make up the published
tetrameric complex [33] are shown in gray.
doi:10.1371/journal.pone.0017946.g001
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structures indicates that the helix-helix dimer is ubiquitous,
suggesting that the contacts at this dimer interface form a
favorable interaction. In contrast, no other contact surface,
including the strand-strand dimer interface, is consistently
conserved among all crystal structures (Table 2 and Fig. 2).
Mutation of W187 in the PR8 NS1 ED leads to a
monomeric form
While the helix-helix interface appears to be the only dimeric
form of NS1 ED consistently observed in all crystal structures, it
remains possible that other dimeric states (such as the strand-
strand dimer) contribute to dimerization in solution. This is
particularly pertinent for the PR8 NS1 ED which may be
predisposed to form the strand-strand dimer in crystal lattices (e.g.
PDB IDs 3O9U and 2GX9 [29]). Previous studies using
recombinant Alb/76 and Ud/72 EDs have shown that a single
W187A amino-acid substitution is sufficient to prevent dimeriza-
tion [28,31]. However, as the strand-strand dimer has never been
observed in structures from these strains, it may be that the PR8
ED behaves differently. We therefore introduced the W187A
mutation into the PR8 NS1 ED bacterial expression construct.
Similar to our Alb/76 study [28], gel filtration of the purified
recombinant protein confirmed that PR8 ED-W187A is likely to
be monomeric as compared with the WT ED dimer, indicating
that no other alternative dimer conformation (including the
strand-strand dimer) forms in solution in the absence of W187
(Fig. 3A).
We crystallized the purified PR8 ED-W187A protein and solved
the structure by molecular replacement. Two crystal forms were
obtained for this protein, both occurring under the same
crystallization condition but separated in time. Initially, the
protein formed large hexagonal crystals belonging to spacegroup
P3221 (PDB ID 3O9Q). However, when the same protein
preparation was used for crystallization 6 months later the protein
formed long needle-shaped crystals, which belonged to spacegroup
P212121 (PDB ID 3O9R). In both crystal forms two ED-W187A
monomers were observed in the asymmetric unit (Fig. 3B).
Surprisingly, both crystal lattices were formed through strand-
strand interactions analogous to the strand-strand dimer observed
in the previously published WT PR8 ED crystals (2GX9, [29]) and
our 3O9U crystals. However, unlike all WT PR8 ED structures
the helix-helix dimer was not present in the W187A crystal lattice.
Together with our gel filtration studies, we conclude that all WT
NS1 EDs predominantly form helix-helix dimers in solution.
While both the WT (dimeric) and W187A (monomeric) PR8 NS1
EDs are capable of forming strand-strand dimers within the
confines of a crystalline array, such dimers do not appear to exist
in solution. Thus, the strand-strand interface seems to be a
Table 1. Data collection and refinement statistics for NS1 effector domains.
PDB ID 3O9S 3O9T 3O9U 3OA9 3O9Q 3O9R
Protein PR8 ED PR8 ED PR8 ED Alb/76 ED PR8 ED (W187A) PR8 ED (W187A)
Space group P212121 C2221 P64 P61 P3221 P212121
Cell dimensions (A˚) a = 48.71 b = 57.02
c = 101.43
a = 72.40 b = 114.87
c = 106.42
a = 114.12 b = 114.12
c = 199.29
a = 47.95, b = 47.95,
c = 231.54
a = 67.52, b = 67.52,
c = 158.98
a = 33.60, b = 70.11,
c = 104.26
Resolution (A˚)* 2.50 (2.54–2.50) 2.20 (2.24–2.20) 3.20 (3.31–3.20) 2.90 (2.95–2.90) 2.50 (2.54–2.50) 2.00 (2.03–2.00)
Rsym (%)* 8.5 (41.6) 4.2 (48.4) 10.2 (59.3) 12.4 (55.3) 4.9 (47.2) 6.2 (32.1)
I/sI* 28.5 (4.3) 30.0 (2.9) 14.8 (2.8) 19.3 (2.8) 43.7 (3.4) 28.7 (2.7)
Completeness (%)* 92.4 (77.0) 96.4 (80.9) 97.2 (80.4) 99.2 (90.6) 99.4 (99.0) 95.5 (63.5)
Unique reflections 9692 22031 23562 6694 15144 16609
Redundancy 6.3 3.3 4.2 4.9 6.0 3.5
Rwork (%) 19.6 24.2 17.5 22.0 24.7 19.6
Rfree (%) 25.7 27.0 22.2 22.8 30.2 25.3
Protein atoms 1895 1869 7247 1791 1885 1836
Water atoms 102 28 0 16 30 206
Rmsd bonds (A˚) 0.008 0.026 0.008 0.01 0.008 0.008
Rmsd angles (u) 1.126 2.004 1.165 1.344 1.082 1.048
Average Bfactor 36.0 42.6 85.8 41.2 66.0 30.6
Structures of PR8 ED-WT, PR8 ED-W187A, and Alb/76 ED-WT were solved by molecular replacement using existing PR8 and Alb/76 structures (PDB IDs 2GX9 and 3D6R).
*Values in parentheses are for highest resolution shell.
doi:10.1371/journal.pone.0017946.t001
Table 2. Occurrence of proposed dimeric arrangements in
NS1 ED structures solved to date.
Strain Spacegroup PDB ID
Monomers in
asymmetric
unit Helix-Helix
Strand-
Strand
PR8 P4322 2GX9 2 4 4
PR8 P64 3O9U* 8 4 4
PR8 P212121 3O9S* 2 4 8
PR8 C2221 3O9T* 2 4 8
Alb/76 P6522 3D6R 2 4 8
Alb/76 P61 3OA9* 2 4 8
Ud/72 C2221 3EE8 2 4 8
Ud/72 P212121 3EE9 2 4 8
Cal/09 P21 3M5R 6 4 8
New crystal structures reported here are marked with an asterisk.
doi:10.1371/journal.pone.0017946.t002
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favorable crystallographic contact for the PR8 NS1 ED, but may
not be physiologically relevant. Interestingly, this may be a strain-
specific packing interface as it is not observed in any Alb/76 or
Ud/72 NS1 ED structure (dimeric or monomeric) [30,31], or even
in the full-length VN/04 NS1 structure [27]. Our data cannot,
however, exclude the possibility that the PR8 ED strand-strand
interface is promoted during virus infection by interactions of NS1
with other proteins or by post-translational modifications.
Consequences of breaking the NS1 ED helix-helix
interface: effects on IFN-antagonism and RNA-binding
To assess functional roles of the helix-helix dimer interface in
the context of full-length NS1, we introduced the W187A
mutation into a PR8 NS1 mammalian expression construct. This
mutation disrupts the helix-helix dimer interface resulting in a
monomeric NS1 ED phenotype (Fig. 3A, refs. [28,31]).
Furthermore, although W187 is directly essential for Ud/72
NS1 to bind host CPSF30 (thereby contributing to efficient
inhibition of cellular pre-mRNA post-transcriptional processing
[33]), PR8 NS1 inherently lacks this function [2]. Thus, PR8 NS1
is the ideal NS1 to study helix-helix dimer disruption as mutation
of W187 will not affect its CPSF30-binding properties, which
would not be the case for NS1 proteins of many other influenza A
virus strains.
IFN-antagonism is one of the most studied functions of NS1.
PR8 NS1 is thought to antagonize IFNb promoter activation (at
least in part) by binding to cellular TRIM25, thereby preventing
ubiquitination of the viral RNA sensor, RIG-I [3]. The interaction
of NS1 with TRIM25 requires both the NS1 RBD and ED [3],
although the necessary dimeric state of the ED is unknown. We
therefore assessed the ability of WT or W187A PR8 NS1 proteins
to limit activation of the IFNb promoter in 293T cells using a
standard SeV-induced luciferase reporter assay. As shown in
Fig. 4A, SeV infection induced robust amounts of IFNb
promoter-driven FF-Luc activity relative to constitutively driven
REN-Luc in empty vector transfected cells (set to 100%), but not
in cells expressing the WT or W187A PR8 NS1 constructs. Both
NS1 constructs expressed to similar levels as determined by
western blot analysis of assay lysates (Fig. 4B). To exclude the
possibility of NS1 saturation resulting in no observable difference
in IFN-antagonism, we serially-diluted the amounts of NS1
plasmid used ensuring that the total amount of transfected DNA
remained constant. As shown in Fig. 4C, dilution of each NS1
plasmid resulted in a similar dose-response of NS1-mediated IFN-
antagonism, indicating that the assays were all in the linear range.
We conclude that formation of the NS1 ED helix-helix dimer (via
W187) has limited impact on the ability of PR8 NS1 to inhibit IFN
induction pre-transcriptionally.
Figure 2. The helix-helix ED dimer is present in all known apo ED crystal structures. All observed ED helix-helix dimers oriented via the
left-hand monomer of each pair show the wide range of positions possible for the right-hand monomer. NS1 ED helix-helix dimers arranged as
follows (identified by PDB ID_chains): (top row, from left to right) 3O9T_AA, 3O9T_BB, 3O9S_AB, 2GX9_AB, 3L4Q_AC; (second row) 3O9U_AC,
3O9U_BE, 3O9U_DG, 3O9U_FH; (third row) 3EE9_AB, 3EE8_AA, 3EE8_BB; (fourth row) 3M5R_AB, 3M5R_DE, 3M5R_FG; (fifth row) 3D6R_AB, 3OA9_AB;
(bottom row) 3F5T_AA. New crystal structures reported here are marked with an asterisk. Note that dimers 3O9T_AA, 3L4Q_AC and 3F5T_AA are
excluded from bioinformatic analyses (see Table 3) as they are either in complex with another molecule or are part of a full-length NS1 structure.
doi:10.1371/journal.pone.0017946.g002
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Sequestration of dsRNA by the NS1 RBD has been implicated
in countering several host antiviral mechanisms [3,7,35], although
the primary consequence has been proposed to be antagonism of
the 2’-5’ OAS/RNaseL pathway [7]. A previous study has
implicated NS1 ED dimerization in functionally stabilizing the
RBD [22]. To formally test whether ED dimerization affects the
dsRNA-binding activity of NS1, we used poly I:C pull-down assays
to assess the interaction of WT or W187A NS1 with synthetic
dsRNA. As shown in Fig. 4D, WT NS1 bound efficiently to poly
I:C, while no binding was observed for a dsRNA-binding
incompetent mutant NS1 (R38A) [25,36]. The W187A NS1
mutant appeared to bind poly I:C very inefficiently (Fig. 4D).
Given that the NS1 RNA-binding site resides wholly within the
RBD [37], these data suggest that ability of the NS1 ED to form
helix-helix dimers is crucial for efficient RBD activity. Whether
this is due to enhanced RNA-binding cooperativity of a helix-helix
mediated NS1 oligomer [27], or simply the precise maintenance of
the RBD dimeric structure by an ED dimer [22], is not yet clear.
We speculate that formation of the NS1 ED helix-helix dimer may
have biological implications for PR8 NS1 functions that require
strong RNA-binding, such as antagonism of 2’-5’ OAS/RNaseL
[7], but not for some other functions (e.g. potential direct binding
to TRIM25 [3]).
The helix-helix dimer interface is variable: a transient
dimer?
Although the helix-helix dimer interface is shared by all
structures of the NS1 ED, and may have some biological role in
that RNA-binding activity of NS1 is affected by its disruption, we
noted that in all helix-helix structures the arrangement of the two
ED monomers differs markedly relative to one another. The
considerable variation in angle is not just between dimers from
different strains, but is also observed between different crystal
forms of the same ED (Fig. 2 and Fig. 5A). This suggests an
inherent flexibility to the helix-helix interaction, rather than a
function of specific amino acid differences. Thus, it is possible that
the two ED monomers may be able to adopt a range of
orientations while still remaining in a dimeric state. Such plasticity
at the monomer-monomer interface may be facilitated by the
presence of several highly conserved glycine residues (G179, G183,
G184) at the contact surface of the long a-helix (Fig. 5B). The
absence of side chains at these positions allows the two monomers
to come very close to one another while continuing to permit a
range of orientations. These glycines may therefore constitute part
of a classical GxxxG-like protein-protein interaction motif,
commonly associated with a-helical homotypic binding sites
[38,39]. Such a motif is often seen in the context of transmem-
brane helix interactions, but has also been observed in soluble
proteins such as dimers of SARS-CoV nsp9 [40].
Based on crystal structures of the NS1 ED in complex with
CPSF30 and PI3K, it is clear that the helix-helix dimer is
incompatible with certain NS1-host protein interactions [32,33].
Thus, for such binding events to occur, separation of the two EDs
would be required. In support of this concept, we analysed all the
isolated NS1 ED structures bioinformatically and found that the
helix-helix interface bears several characteristics reminiscent of
transient dimers capable of associating and dissociating [41,42,43]:
the mean interface accessible area is small (513673 A˚2; transient
dimer ,1000 A˚2/subunit), with a small interface gap volume
(32476438 A˚3; transient dimer ,5000 A˚3/subunit), large gap
volume index (3.2260.55 A˚; transient dimer .2.0 A˚), and low
planarity score (RMSD = 2.5360.14 A˚2, transient dimer ,2.5 A˚2)
(Table 3). An additional characteristic of transient dimers is a low
local density (LD) of interacting atoms at the subunit interface.
While obligate dimer interfaces generally have LD values of
around 43, transient interfaces are typified by LD values in the
order of 35 [44]. The ED helix-helix dimer interfaces have a mean
LD of 35.564.7 (Table 3). The combination of all these ‘transient’
features indicates that the helix-helix dimer is likely to be weak and
thus capable of separation, potentially allowing other binding
partners access to the regions buried at the interface. Similar
analyses of the strand-strand dimer interface indicate that these
‘transient’ characteristics are even more pronounced (Table 4),
confirming that this interaction is even weaker than the helix-helix
dimer.
In contrast to the ED dimer interface, the interaction between
monomers of isolated apo RBDs bears more similarity to obligate
Figure 3. Structural analysis of PR8 NS1 ED W187A. (A) PR8 NS1
ED-W187A is monomeric in solution. Gel filtration analysis of the
purified WT and W187A mutant 6His-tagged PR8 NS1 ED proteins at
1mg/mL. The elution volumes of protein standards used to calibrate the
column are indicated at the top: conalbumin (75000 Da), ovalbumin
(43000 Da), carbonic anhydrase (29000 Da) and ribonuclease A
(13700 Da). The estimated MWs of WT and W187A PR8 EDs are shown
together with their ratio to the calculated MW of the respective
monomeric protein. Calibrations and calculations were performed as
previously described [28]. (B) Crystals of PR8 NS1 ED-W187A form
by strand-strand packing. Two crystal forms of the PR8 NS1 ED
W187A monomeric mutant revealing strand-strand packing in the
crystal lattice. The two monomers of each form are colored dark or light
blue (PDB IDs 3O9Q and 3O9R, respectively).
doi:10.1371/journal.pone.0017946.g003
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than transient dimer interfaces (Table 5). In particular, the gap
volume index is much lower (1.6260.23 A˚) and planarity much
higher (3.7960.31 A˚) than observed in ED dimers. Although the
interface accessible area and gap volume are still quite small
(1122660 A˚2 and 36116332 A˚3, respectively) these values are
likely more influenced by the size of the domain than gap volume
index and planarity. However, examination of the interface
surface area as a percentage of total surface area indicates that a
relatively high proportion of the protein surface is involved in the
interaction (21.460.9%, obligate dimer .20% [43]), which is in
stark contrast to the ED helix-helix dimer interface (7.561.3%)
(Tables 3 and 5). These bioinformatic analyses suggest that the
RBD forms a stable obligate homodimer, while the ED helix-helix
dimer (although predominant over other interfaces) may only be
weak and transient.
Can the transient NS1 helix-helix dimer be observed in
virus-infected cells?
While characterizing the functional impact of mutating W187,
we serendipitously found that our V5-tagged W187A PR8 NS1
mutant construct was not recognized by the NS1-specific mAb
1A7, either by western blot on SDS-PAGs or by immunofluores-
cence (Figs. 6A & 6B). For SDS-PAGE, our cell lysis and gel
loading buffer contained 6 M urea, 2 M b-mercaptoethanol and
4% SDS that, combined with boiling, should be more than
sufficient to completely denature all secondary, tertiary and
quaternary structures of NS1. This was clearly evidenced by its
apparent mobility on the polyacrylamide gel, which corresponded
to its primary sequence molecular weight (Fig. 6A). Thus,
although we have not completely mapped the epitope of this
antibody, the data strongly suggest that mAb 1A7 recognizes a
linear epitope that absolutely requires W187. Given that W187 is
completely buried within the ED helix-helix interface, and is not
solvent exposed on this dimer surface (Fig. 1B), we reasoned that
1A7 would be unable to recognize the helix-helix ED dimer if this
conformation actually exists. We therefore used 1A7 alongside a
rabbit polyclonal NS1-specific anti-serum (pAb 155) to try and
observe different sub-populations of NS1 in WT virus-infected
cells, which we hypothesized may correlate with W187-exposed
(‘helix-open’) or W187-buried (‘helix-closed’) conformations of
NS1. MDCK cells were infected with WT rPR8 virus at an MOI
of 2 PFU/cell and fixed at various times post-infection. Use of the
PR8 strain prevented confounding issues regarding CPSF30
binding, which is also mediated by exposed W187 [33].
Figure 4. Biological role of the NS1 ED helix-helix dimer interface. (A) Ability of the PR8 NS1-W187A mutant to antagonize IFNb
induction. 293T cells were co-transfected for 16 h with a pCAGGS expression plasmid encoding the indicated PR8 NS1 protein (or vector only), a FF-
Luc IFNb-promoter reporter plasmid (p125Luc), and a constitutively active HSV-TK promoter driven REN-Luc reporter plasmid (pRL-TK). After infection
with SeV for a further 12 h, both FF-Luc and REN-Luc activities were determined. Results represent the means and standard deviations of triplicate
values (FF-Luc normalized to REN-Luc) obtained in a single experiment, and are representative of two independent experiments. Vector + SeV was set
to 100%. (B) Western blot analysis of lysates from (A). NS1 and actin were detected using rabbit polyclonal antibodies. Molecular weight markers
(kDa) are indicated to the right. (C) Assay repeated as for (A) but using 3.3-fold serial dilutions of pCAGGS plasmid. Total amounts of transfected DNA
were kept constant. (D) Ability of PR8 NS1 mutants to bind synthetic dsRNA. Lysates from 293T cells transfected with the indicated V5-tagged
PR8 NS1 construct were precipitated with pI:C-Sepharose (pI:C) or Sepharose only (2). Following SDS-PAGE, NS1-V5 proteins were detected by
western blot. Molecular weight markers (kDa) are indicated to the right.
doi:10.1371/journal.pone.0017946.g004
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Subsequent co-staining with mAb 1A7 and pAb 155 did indeed
reveal distinct NS1 populations recognized by the two antibodies
(Fig. 6C). While pAb 155 highlighted both nuclear and
cytoplasmic NS1 at 8 and 12 h post-infection, mAb 1A7
predominantly recognized only nuclear NS1 at these timepoints.
However, at 24 h post-infection, both antibodies showed a similar
pattern of NS1 distribution, which was divided equally between
nucleus and cytoplasm. Uninfected cells within the fields-of-view
acted as internal controls to ensure that observed differences were
not due to differential background staining by the antibodies
(Fig. 6C). In addition, by carefully optimizing the microscope
settings for the 24 h timepoint (when NS1 levels are the highest),
and not changing any conditions when switching slides or
fluorescent channels, we minimized oversaturation issues. To
ensure further that our image interpretations were not biased by
potential differences in intensity of the two fluorescent channels of
our microscope, we quantified the ratio of nuclear-to-cytoplasmic
NS1 staining for both pAb 155 and mAb 1A7 at each timepoint.
This ‘within-channel’ quantification totally eliminates bias, and
clearly confirmed that mAb 1A7 predominantly recognizes
nuclear NS1 at the 8 and 12 h timepoints, while pAb 155
recognizes a more even distribution (Fig. 6C). We also performed
nucleo-cytoplasmic fractionation and immunoblotting of infected
cells to show that total amounts of NS1 are actually slightly higher
in the cytoplasm than the nucleus at all timepoints, further
indicating that the observed differences are not due to relative
protein abundance (Fig. 6D). Overall, these data suggest that at 8
and 12 h post-infection, W187 is exposed in the nucleus, while it is
largely hidden in the cytoplasm, most likely by homotypic ED
interactions. Given that at 24 h post-infection mAb 1A7 can
recognize both nuclear and cytoplasmic NS1 in a manner similar
to pAb 155 (Fig. 6C), we speculate that the cytoplasmic NS1 at
this timepoint adopts a different conformation than the cytoplas-
mic NS1 at 8 and 12 h, namely that W187 is now exposed (‘helix-
open’).
Discussion
Although much is known about the plethora of molecular
interactions between influenza A virus NS1 protein and cellular
factors [1], surprisingly few studies have addressed potential
mechanisms by which NS1 multifunctionality is achieved. Present
models of the tertiary and quaternary structures of NS1 indicate
that the protein possesses two globular domains, each capable of
forming independent homodimeric interactions. Our bioinfor-
matic analyses indicate that the N-terminal RBD forms a very
stable homodimer, while the predominant and ubiquitous helix-
helix contacts between C-terminal EDs bear many similarities with
weak transient interfaces. Thus, while the RBD dimer is likely to
remain constant, the ED may move between monomeric and
dimeric states. We therefore propose a new model of NS1
functional regulation dependent upon several different molecular
arrangements of the protein, which may be temporally, spatially,
interaction, or modification induced. Our model is summarized in
Fig. 7.
By integrating structural and biochemical data, we have very
tentatively identified at least two NS1 conformations in virus-
infected cells, which we have termed ‘helix-open’ (monomeric ED
conformation) and ‘helix-closed’ (dimeric ED helix-helix confor-
mation, or shielding by another cellular/viral protein). The exact
biological function of these possible NS1 conformational states has
yet to be fully defined, yet some information is already available.
For example, our studies using a mAb that should not recognize
the ‘helix-closed’ conformation suggest that the two conformations
may have specific spatio-temporal distributions during virus
infection. Furthermore, the rationally-designed ‘helix-open’ NS1
protein (W187A) was poor at binding synthetic dsRNA, perhaps
indicating that ED helix-helix dimeric interactions allosterically
increase affinity of the RBD for dsRNA, or that ED homotypic
interactions facilitate oligomerization of NS1 and thus cooperative
binding to dsRNA. In this regard, it is worth noting that a previous
study proposed a multimeric state of NS1 composed of extensive
repeating chains of ‘domain-swapped dimers’ [27]. The chains
were noted in a crystal lattice of full-length VN/04 NS1, and may
explain the long NS1 filaments formed at high protein
concentrations [27]. The precise role, if any, of such filaments is
unknown, although NS1 ‘tubules’ made up of multiple filaments
Figure 5. The NS1 ED forms a flexible dimer via the helix-helix
interface. (A) Superposition of all ED helix-helix dimers oriented via
the left-hand monomer of each pair to show the wide range of
positions possible for the right-hand monomer, thus indicating a high
degree of interface flexibility. (B) Highlighted GxxxG-like motif present
at the helix-helix interface.
doi:10.1371/journal.pone.0017946.g005
Influenza Virus NS1 Multimerization
PLoS ONE | www.plosone.org 7 March 2011 | Volume 6 | Issue 3 | e17946
were proposed to be involved in cooperatively binding dsRNA
[27]. Our data may therefore be consistent with such a general
multimerization model, although it is clear from both previous
studies [23], and the actual structure of dsRNA in complex with
the RBD [25], that NS1 ‘tubules’ are incompatible with dsRNA
binding, as dsRNA would be positioned perpendicular to the chain
of NS1 molecules. Thus, any dsRNA binding cooperativity
exhibited by NS1 ED helix-helix dimerization or multimerization
is likely to be independent of the ‘tubules’ seen in the VN/04
crystal lattice [27].
Evidence from the published crystal structures of NS1 ED in
complex with domains from cellular proteins also confirms that the
Table 3. Bioinformatic analysis of isolated NS1 ED helix-helix dimer characteristics.
Strain Dimer
Symmetry
relationship
Interface
accessible
surface area (A˚2)*
Interface
accessible
surface area (%)* Planarity (A˚)* Local density**
Gap Volume
(A˚3)*
Gap Volume
Index (A˚)*
PR8 2GX9_ABHH asymmetric 475 6.1 2.72 31.2 2943 3.10
3O9U_AC asymmetric 426 6.4 2.58 27.5 3554 4.18
3O9U_BE asymmetric 432 6.5 2.64 28.7 3115 3.61
3O9U_DG asymmetric 495 7.3 2.34 35.8 3915 3.96
3O9U_FH asymmetric 526 8.0 2.42 35.7 3439 3.27
3O9S_AB asymmetric 447 6.5 2.37 31.2 2886 3.23
3O9T_AA1 symmetric 551 8.48 2.36 37.8 2197 1.99
3O9T_BB symmetric 551 7.9 2.64 39.1 3854 3.50
Alb/76 3D6R_AB asymmetric 698 10.9 2.39 39.7 3247 2.33
3OA9_AB asymmetric 587 9.3 2.42 39.7 2447 2.08
Ud/72 3EE8_AA symmetric 436 6.4 2.46 30.3 2687 3.08
3EE8_BB symmetric 486 7.1 2.79 31.4 2754 2.83
3EE9_AB asymmetric 597 8.8 2.47 40.6 3459 2.90
Cal/09 3M5R_AB asymmetric 510 6.8 2.54 40.7 3689 3.62
3M5R_DE asymmetric 507 7.5 2.64 39.7 3230 3.18
3M5R_FG asymmetric 516 7.6 2.58 39.6 3483 3.38
VN/04 3F5T_AAED{ symmetric 570 8.3 2.40 38.5 4725 4.14
Mean 513 7.5 2.53 35.5 3247 3.22
Standard
deviation
73 1.3 0.14 4.7 438 0.55
ED helix-helix dimers identified as PDB ID_chains (e.g. dimer 3O9U_AC is formed by chains A and C of structure 3O9U). The helix-helix dimer formed by chains A and B of
PR8 ED structure 2GX9 is identified by a superscript HH to distinguish it from the strand-strand dimer also made by those chains (see Table 4). The ED dimer formed by
chain A of the full-length VN/04 NS1 structure 3F5T is distinguished from the RBD dimer formed by the same chain (see Table 5) by a superscript ED. All values
calculated using either ProtorP (*) or ProFace (**). Symmetric dimer 3O9T_AA (1) is excluded from calculation of mean and standard deviation due to the presence of a
molecule of PEG2000 at the helix-helix dimer interface. To facilitate fair comparison, the VN/04 NS1 ED symmetric dimer 3F5T_AAED({) was not included in the
calculations as it is part of a full-length NS1 structure.
doi:10.1371/journal.pone.0017946.t003
Table 4. Bioinformatic analysis of isolated NS1 ED strand-strand dimer characteristics.
Strain Dimer
Symmetry
relationship
Interface
accessible
surface area (A˚2)*
Interface
accessible
surface area (%)* Planarity (A˚)* Local density**
Gap Volume
(A˚3)*
Gap Volume
Index (A˚)*
PR8 2GX9_ABSS asymmetric 603 7.7 2.51 32.3 5812 4.82
3O9U_AF asymmetric 345 5.2 2.66 22.9 4357 6.31
3O9U_BD asymmetric 442 6.6 2.47 25.5 4165 4.71
3O9U_CH asymmetric 482 7.3 2.21 30.4 5461 5.67
3O9U_EG asymmetric 514 7.7 2.48 31.6 5883 5.73
Mean 477 6.9 2.47 28.5 5135 5.45
Standard
deviation
95 1.1 0.16 4.1 817 0.67
ED strand-strand dimers identified as PDB ID_chains (e.g. dimer 3O9U_AF is formed by chains A and F of structure 3O9U). The strand-strand dimer formed by chains A
and B of PR8 structure 2GX9 is identified by a superscript SS to distinguish it from the helix-helix dimer also made by those chains (see Table 3). All values calculated
using either ProtorP (*) or ProFace (**).
doi:10.1371/journal.pone.0017946.t004
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Table 5. Bioinformatic analysis of isolated NS1 RBD dimer characteristics.
Strain Dimer
Symmetry
relationship
Interface
accessible
surface area
(A˚2)*
Interface
accessible
surface area
(%)* Planarity (A˚)* Local density**
Gap Volume
(A˚3)*
Gap Volume
Index (A˚)*
PR8 2ZKO_AB1 asymmetric 1054 19.9 3.22 35.8 3527 1.67
Ud/72 1AIL_AA symmetric 1019 20.3 4.08 35.3 4330 2.12
Cal/09 3M8A_AG asymmetric 1152 22.4 3.60 39.4 3419 1.48
3M8A_BH asymmetric 1115 21.8 3.58 38.1 3540 1.59
3M8A_CF asymmetric 1192 22.3 4.01 40.0 3466 1.45
3M8A_DE asymmetric 1115 21.4 3.39 39.1 3378 1.52
3M8A_IL asymmetric 1181 21.8 4.22 39.2 3679 1.56
3M8A_JK asymmetric 1081 20.2 3.62 39.7 3466 1.60
VN/04 3F5T_AARBD{ symmetric 715 14.0 4.37 27.2 4691 3.28
Mean 1122 21.4 3.79 38.7 3611 1.62
Standard
deviation
60 0.9 0.31 1.6 332 0.23
RBD dimers identified as PDB ID_chains (e.g. dimer 3M8A_AG is formed by chains A and G of structure 3M8A). RBD dimer formed by chain A of the full-length NS1
structure 3F5T distinguished from the ED dimer formed by the same chain (see Table 3) by a superscript RBD. All values calculated using either ProtorP (*) or ProFace
(**). PR8 dimer 2ZKO_AB (1) is excluded from calculation of mean and standard deviation as it is in complex with a molecule of dsRNA. To facilitate fair comparison, the
VN/04 NS1 RBD symmetric dimer 3F5T_AARBD({) was not included in the calculations as it is part of a full-length NS1 structure.
doi:10.1371/journal.pone.0017946.t005
Figure 6. Possible visualization of ‘helix-open’ and ‘helix-closed’ NS1 ED conformational states in virus-infected cells. (A) mAb 1A7
does not recognize NS1-W187A. Western blot analysis of lysates from 293T cells transfected with pCAGGS expression plasmids encoding the
indicated V5-tagged PR8 NS1 protein (or vector only). NS1 was detected using both rabbit anti-V5 pAb and mouse mAb 1A7. Actin served as a
loading control. Molecular weight markers (kDa) are indicated to the right. (B) Indirect immunofluorescence analysis of NS1 proteins in MDCK cells
transfected with pCAGGS expression plasmids encoding the indicated V5-tagged PR8 NS1 protein. Cells were fixed approximately 24 h post-
transfection. Co-staining was performed using rabbit anti-V5 pAb and mouse mAb 1A7. (C) mAb 1A7 and pAb 155 highlight different NS1
populations during infection. Indirect immunofluorescence analysis of NS1 protein localization in MDCK cells infected for the indicated times
with rPR8 WT virus (MOI of 2 PFU/cell). Co-staining was performed using rabbit anti-NS1 pAb 155 and mouse mAb 1A7. Asterisks indicate example
uninfected cells to show background staining. Bar graphs represent the mean nuclear/cytoplasmic (N/C) ratios of mean fluorescent intensities derived
from manually assigned individual nuclei and cytoplasms for each fluorescent channel (n = 25 cells per timepoint, error bars represent standard
deviations). The dotted line indicates a nuclear/cytoplasmic ratio of 1. (D) Western blot analysis of nucleo-cytoplasmic extracts prepared from MDCK
cells infected as for (C). The primary antibody was a polyclonal rabbit anti-serum raised against a GST-NS1 (RBD) fusion protein. *Cyto indicates a non-
specific band that co-purifies solely with the cytoplasmic fractions and thus highlights purification integrity. **Total indicates a non-specific band
found in all fractions that serves as a convenient loading control. Molecular weight markers (kDa) are indicated to the right.
doi:10.1371/journal.pone.0017946.g006
Influenza Virus NS1 Multimerization
PLoS ONE | www.plosone.org 9 March 2011 | Volume 6 | Issue 3 | e17946
ED helix-helix interface must be able to separate [32,33]. The
NS1 proteins of most influenza A virus strains bind the nuclear-
localized 30 kDa subunit of cleavage and polyadenylation
specificity factor (CPSF30) as a mechanism to suppress general
host gene expression [2,4,13,15]. The CPSF30 binding site on
NS1 overlaps extensively with the ED helix-helix dimer interface
[28,33], indicating that the NS1:CPSF30 complex and the NS1
‘helix-closed’ conformations are mutually exclusive. It is highly
likely that the affinity of NS1 for CPSF30 is much higher than that
of its homotypic interaction, at least in the absence of any other
stabilizing factors. The ability of NS1 to only interact with
CPSF30 when in the ‘helix-open’ state is a prediction consistent
with our observation that this NS1 conformation is predominantly
found in the nucleus at early times post-infection, when
suppression of host-cell gene expression may be most critical.
NS1 also activates host cytoplasmic PI3K signaling at mid-times
post-infection by directly binding the p85b regulatory subunit of
this enzyme [9]. We recently reported the crystal structure of this
interaction [32], and while the ‘helix-closed’ conformation of NS1
does not preclude binding to p85b, our careful modelling of the
complete heterotrimeric NS1:PI3K complex suggested that the
‘helix-closed’ NS1 state was unlikely to be relevant in a biological
context due to steric clashes with the membrane upon which active
PI3K must be associated. Thus, binding of NS1 to either CPSF30
or PI3K would require ‘helix-open’ conformations. Although we
apparently only detect a small proportion of ‘helix-open’ NS1 in
the cytoplasm relative to nucleus at 8 h post-infection, this may be
explained by the fact that NS1-mediated activation of PI3K is a
catalytic process, thus requiring few NS1 molecules, whereas
CPSF30 inhibition requires stoichiometric sequestration by many
NS1 molecules. In addition, the kinetics of NS1 performing its
many functions are far from clear, and several other factors
beyond those discussed here are likely to affect the conformational
state of NS1. Indeed, in our model, we envisage that certain
cellular interactions or post-translational modifications, such as
phosphorylation [10] or SUMOylation [12], may temporally and
spatially regulate NS1 conformations.
A key aspect of our functional model is the instability and
flexibility of the NS1 ED helix-helix dimer, which seems weak and
transient in vitro, but may be slightly more stable in the context of
the full-length protein, or become more permanent in the presence
of certain binding partners. ED dimer flexibility is likely permitted
by the presence of several glycine residues at the homodimer
interface (a putative GxxxG protein-protein interaction motif) that
allow the two helices to rotate easily relative to one another.
Mutation of one of these glycines to a charged bulky residue
(G184R) has recently been reported to decrease efficient virus
replication and virulence in a mouse model without affecting
tissue-culture replication or the IFN-antagonistic properties of
NS1 [45]. This substitution is highly likely to have altered the
flexibility between, or self-association of, two homotypic EDs.
Interestingly, previous gross truncation of the NS1 ED to prevent
dimerization also had minimal impact on virus replication in
tissue-culture, but substantially reduced virulence in mice, a
property largely reversed by artificially grafting a heterologous
multimerization motif onto the truncated NS1 protein [22].
Many functions of NS1 are strain-specific [2,5,13,14,15,17,18],
and there is evidence to suggest that NS1 ED dimerization may
also vary between influenza A virus strains. In particular, a
previous report found that the Ud/72 NS1 ED requires
concentrations in excess of 0.3 mM (approximately 5 mg/mL)
for dimerization to occur [31]. Our preliminary results also
indicate that at 0.06 mM (approximately 1 mg/mL) the purified
Ud/72 NS1 ED is predominantly monomeric (data not shown).
However, at this same concentration we routinely observe
complete dimerization of the PR8 and Alb/76 NS1 EDs. It is
tempting to speculate that ED dimerization affinity may contribute
to some of the strain-specific activities that NS1 performs,
particularly if the NS1 ED of some strains is more likely than
others to self-associate.
Multiple NS1 ED positions are likely facilitated by the short
flexible inter-domain linker that exists between the RBD and ED
(usually residues 74–86). Presence of this linker suggests that the
RBD and ED are never spatially fixed relative to one another, with
independent dimerization of each domain occurring. Intriguingly,
inter-domain linker length can also vary between influenza A virus
strains, and evidence suggests that a 5 amino-acid deletion in this
region significantly impacts upon virulence [18]. The exact
mechanism by which this is achieved is not well understood,
although we postulate that shorter linkers may restrict the range of
positions potentially adopted by the NS1 ED.
Weak transient protein:protein interactions that readily associ-
ate and disassociate are an important regulatory mechanism
adopted by several multifunctional cellular proteins [46]. Here, we
have used structural, bioinformatic, and biological evidence to
propose a similar mode of action for the influenza A virus NS1
Figure 7. Hypothetical model of NS1 ED transient homotypic
interactions. Cartoon summarizing various possible states of the NS1
ED in the context of the full-length protein. The flexible inter-domain
linker permits a range of ED conformations from ‘helix-open’ to ‘helix-
closed’. Such variability is promoted by the helix-helix interface being
weak and transient. The mAb 1A7 only recognizes NS1 when W187 is
exposed (‘helix-open’). Some functions potentially associated with each
conformer are listed. It is likely that certain states are temporally or
spatially regulated during infection, either by protein-protein interac-
tions or by post-translational modifications. The NS1 monomers are
colored green and wheat. The dsRNA is colored in shades of blue to
represent possible different binding affinities to NS1. Models generated
using the following PDB IDs: 3F5T, 2RHK, and 2ZKO.
doi:10.1371/journal.pone.0017946.g007
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protein, an important virulence factor. Our new hypothetical
model may help explain how such a small protein has been able to
expand its number of cellular and viral binding partners. Further
work to accurately define the existence and potential regulation of
NS1 conformers in solution, both structurally and during infection,
will be essential for understanding some of the complexities of this
remarkable protein.
Materials and Methods
Protein expression and purification
The pRSFDuet-1 plasmid expressing a 6His-tagged version of
the Alb/76 NS1 ED (residues 73–230) has been described
previously [28]. The same cloning strategy was used to generate
a plasmid for expression of a 6His-tagged version of the PR8 NS1
ED (residues 73–230). Four-primer overlap PCR was used to
specifically introduce nucleotide changes encoding the W187A
mutation into the PR8 NS1 ED cDNA. The identity of each
construct was confirmed by commercial DNA sequencing.
Recombinant 6His-tagged NS1 EDs were expressed in E. coli
strain BL-21 (DE3), purified, 6His-tag removed, and gel filtrated
as described previously [28].
Crystallization, data collection and structure solution/
refinement
Crystals were obtained by vapor diffusion in hanging drops
consisting of 2 mL concentrated protein solution (approx 8–
10 mg/mL in 50 mM Tris-HCl [pH 7.8], 0.2 M NaCl) and 2 mL
of reservoir solution. Reservoir solutions for each structure were as
follows (identified by PDB ID): 3O9S (12% PEG 3350, 0.05 M
NaSCN, 0.1 M Bis-Tris [pH 5.5], 15% glycerol, 0.05 M DTT);
3O9T (0.1 M Tris-HCl [pH 6.5], 0.1 M NaCl, 20% PEG 4K);
3O9U (0.1 M Tris-HCl [pH 6.5], 0.2 M NaCl, 25% PEG 6K);
3OA9 (0.2 M sodium formate, 20% PEG 3350). For both 3O9Q
and 3O9R the reservoir solution was 0.1 M HEPES [pH 7.0],
0.2 M NaCl, 22% PEG 6K, 10% isopropanol, 10% glycerol.
Data were collected on an in-house rotating anode (RA Micro7
HFM) and a Saturn944 CCD at 100K and processed with
HKL2000 [47]. Structures were solved by molecular replacement
using PHASER [48] and refined using Refmac5 [49] and
PHENIX [50] with manual model building using O [51] and
Coot [52]. Figures were created using PyMol [53].
Bioinformatic Analyses
Domain interface characterization was performed using a
dataset comprised of both novel NS1 structures and coordinates
from the PDB database. Structures of full-length NS1 or domains
in complex with other molecules (e.g. dsRNA or p85b) were
excluded from the dataset. Properties of each interface were
calculated using ProtorP [54] and ProFace [55].
Mammalian cells and antibodies
293T and MDCK cells were purchased from the American
Type Culture Collection (ATCC, VA, USA) and maintained in
DMEM supplemented with 10% FBS, 100 units/mL of penicillin,
and 100 mg/mL of streptomycin (GIBCO Life Technologies, CA,
USA). Mouse and rabbit anti-V5 antibodies were purchased from
Serotec (UK), and rabbit anti-actin was from Sigma-Aldrich (MO,
USA). The rabbit polyclonal NS1 anti-serum (pAb 155) was kindly
provided by Peter Palese (Mount Sinai School of Medicine, USA).
The rabbit polyclonal NS1 anti-serum raised against a GST-NS1
(RBD) fusion protein was used previously [15]. The anti-NS1
hybridoma (mAb clone 1A7) was a generous gift from Jonathan
Yewdell (Laboratory of Viral Diseases, NIAID, NIH, USA).
Plasmids
A mammalian expression construct for C-terminally V5-tagged
PR8 NS1 under control of the chicken b-actin promoter was
generated by amplifying the entire PR8 NS1-V5 ORF from an
existing clone [9] and ligating it into the EcoRI and XhoI
restriction sites of pCAGGS [56]. As required, four-primer overlap
PCR was used to introduce site-directed point mutations into the
NS1-encoding cDNA. All NS1-encoding cDNAs also contained
silent mutations in the splice acceptor site in order to prevent
expression of NS2/NEP [9]. The reporter plasmid with the firefly
luciferase (FF-Luc) gene under control of the IFNb promoter
(p125Luc) was kindly provided by Takashi Fujita (Kyoto
University, Japan) [57]. The reporter plasmid with the Renilla
luciferase gene (REN-Luc) under control of the constitutively
active HSV-TK promoter (pRL-TK) was purchased from
Promega, WI, USA. Identity of each new construct was confirmed
by commercial DNA sequencing.
Viruses
Stocks of Sendai virus (SeV; Cantell strain) propagated in 10-
day old embryonated chicken eggs were kindly provided by Silke
Stertz (Mount Sinai School of Medicine, USA). Recombinant
rPR8 (wild-type, WT) was rescued according to a previously
reported protocol [15], albeit using PR8 RNA expression
plasmids. The plaque-purified rescued virus was propagated and
titrated in MDCK cells, and the genotype confirmed by RT-PCR
and sequencing of the entire NS segment.
IFNb reporter assays
For analysis of IFNb promoter activation, 293T cells in 12-well
plates were transfected with 25 ng of p125Luc, 25 ng of pRL-TK,
and the indicated amount of PR8 NS1-V5 (or empty vector)
expression plasmid using FuGENE6 (Roche, WI, USA). After
16 h, the cells were infected with approximately 1 PFU/cell of
SeV for 12 h. Cells were harvested and lysed in 200 mL of passive
lysis buffer (Promega, WI, USA), and both FF-Luc and REN-Luc
activities were determined using the Dual-LuciferaseH reporter
assay system as directed by the manufacturer (Promega, WI,
USA). All transfections were carried out in triplicate, and
experiments were independently repeated twice.
Poly(rI):poly(rC)-Sepharose pull-downs, SDS-PAGE and
western blot
Poly(rI):poly(rC) (pI:C) Sepharose pull-downs were performed
as described [15], albeit using transiently-expressed (293T) PR8
NS1-V5 proteins as bait. Nucleo-cytoplasmic extracts were
prepared using commercial nuclear and cytoplasmic extraction
reagents (NE-PERH, Thermo Scientific, IL, USA). For western
blot analysis, lysates were prepared in disruption buffer (6 M urea,
2 M b-mercaptoethanol, 4% SDS), sonicated to shear nucleic
acids, and boiled for 5 min prior to polypeptide separation by
SDS-PAGE on 4–15% Tris-HCl gradient gels (Bio-Rad Labora-
tories, CA, USA). Proteins were detected by standard western blot
techniques following transfer to polyvinylidene difluoride (PVDF)
membranes.
Immunofluorescence studies
For indirect immunofluorescence staining, MDCK cells were
seeded onto glass-bottomed 12-well culture plates and transfected
(1 mg plasmid per well) or infected (2 PFU/cell) as described
above. At the indicated times, cells were fixed and permeabilized
with ice-cold methanol for 5 min at 4uC and blocked for 1 h in
PBS containing 1% bovine serum albumin (BSA). Primary
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antibodies (see above) were incubated with the samples for 1 h at
room temperature. Secondary antibodies (goat anti-mouse Alexa
Fluor 633 or goat anti-rabbit Alexa Fluor 488, Invitrogen, USA)
were incubated with the samples at a 1:1000 dilution prior to
fluorescence imaging using a Zeiss LSM 510 Meta confocal
microscope. Mean fluorescence intensities of manually selected
nuclei and cytoplasms were quantified using ImageJ [58].
Acknowledgments
We are grateful to Jonathan Yewdell (NIH, MD, USA), Peter Palese
(Mount Sinai School of Medicine, NY, USA), Takashi Fujita (Kyoto
University, Japan), Balaji Manicassamy (Mount Sinai School of Medicine,
NY, USA), Silke Stertz (Mount Sinai School of Medicine, NY, USA), and
Huanting Lui (University of St. Andrews, UK) for kind provision of
reagents and advice. We also thank Luis Martı´nez-Sobrido (University of
Rochester, NY, USA) and Georg Kochs (University of Freiburg, Germany)
for sharing preliminary observations relating to the specificity of mAb 1A7.
Richard Cadagan and Osman Lizardo (Mount Sinai School of Medicine,
NY, USA) provided excellent technical assistance. All newly derived
coordinates and structure factors have been deposited with the Protein
Data Bank (accession codes 3OA9, 3O9Q, 3O9R, 3O9S, 3O9T, and
3O9U).
Author Contributions
Conceived and designed the experiments: PSK BGH RJR. Performed the
experiments: PSK JA MAT CH AL BGH RJR. Analyzed the data: PSK
AGS RER BGH RJR. Wrote the paper: PSK BGH AGS RJR.
References
1. Hale BG, Randall RE, Ortin J, Jackson D (2008) The multifunctional NS1
protein of influenza A viruses. J Gen Virol 89: 2359–2376.
2. Kochs G, Garcia-Sastre A, Martinez-Sobrido L (2007) Multiple anti-interferon
actions of the influenza A virus NS1 protein. J Virol 81: 7011–7021.
3. Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, et al. (2009) Influenza A
virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host
viral RNA sensor RIG-I. Cell Host Microbe 5: 439–449.
4. Nemeroff ME, Barabino SM, Li Y, Keller W, Krug RM (1998) Influenza virus
NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits
3’end formation of cellular pre-mRNAs. Mol Cell 1: 991–1000.
5. Hayman A, Comely S, Lackenby A, Murphy S, McCauley J, et al. (2006)
Variation in the ability of human influenza A viruses to induce and inhibit the
IFN-beta pathway. Virology 347: 52–64.
6. Li S, Min JY, Krug RM, Sen GC (2006) Binding of the influenza A virus NS1
protein to PKR mediates the inhibition of its activation by either PACT or
double-stranded RNA. Virology 349: 13–21.
7. Min JY, Krug RM (2006) The primary function of RNA binding by the
influenza A virus NS1 protein in infected cells: Inhibiting the 2’-5’ oligo (A)
synthetase/RNase L pathway. Proc Natl Acad Sci U S A 103: 7100–7105.
8. Burgui I, Aragon T, Ortin J, Nieto A (2003) PABP1 and eIF4GI associate with
influenza virus NS1 protein in viral mRNA translation initiation complexes.
J Gen Virol 84: 3263–3274.
9. Hale BG, Jackson D, Chen YH, Lamb RA, Randall RE (2006) Influenza A virus
NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling.
Proc Natl Acad Sci U S A 103: 14194–14199.
10. Hale BG, Knebel A, Botting CH, Galloway CS, Precious BL, et al. (2009)
CDK/ERK-mediated phosphorylation of the human influenza A virus NS1
protein at threonine-215. Virology 383: 6–11.
11. Zhao C, Hsiang TY, Kuo RL, Krug RM (2010) ISG15 conjugation system
targets the viral NS1 protein in influenza A virus-infected cells. Proc Natl Acad
Sci U S A 107: 2253–2258.
12. Xu K, Klenk C, Liu B, Keiner B, Cheng J, et al. (2011) Modification of
nonstructural protein 1 of influenza A virus by SUMO1. J Virol 85: 1086–1098.
13. Twu KY, Kuo RL, Marklund J, Krug RM (2007) The H5N1 influenza virus NS
genes selected after 1998 enhance virus replication in mammalian cells. J Virol
81: 8112–8121.
14. Heikkinen LS, Kazlauskas A, Melen K, Wagner R, Ziegler T, et al. (2008) Avian
and 1918 Spanish influenza a virus NS1 proteins bind to Crk/CrkL Src
homology 3 domains to activate host cell signaling. J Biol Chem 283:
5719–5727.
15. Hale BG, Steel J, Medina RA, Manicassamy B, Ye J, et al. (2010) Inefficient
control of host gene expression by the 2009 pandemic H1N1 influenza A virus
NS1 protein. J Virol 84: 6909–6922.
16. Seo SH, Hoffmann E, Webster RG (2002) Lethal H5N1 influenza viruses escape
host anti-viral cytokine responses. Nat Med 8: 950–954.
17. Liu H, Golebiewski L, Dow EC, Krug RM, Javier RT, et al. (2010) The ESEV
PDZ-Binding Motif of the Avian Influenza A Virus NS1 Protein Protects
Infected Cells from Apoptosis by Directly Targeting Scribble. J Virol 84:
11164–11174.
18. Long JX, Peng DX, Liu YL, Wu YT, Liu XF (2008) Virulence of H5N1 avian
influenza virus enhanced by a 15-nucleotide deletion in the viral nonstructural
gene. Virus Genes 36: 471–478.
19. Volmer R, Mazel-Sanchez B, Volmer C, Soubies SM, Guerin JL (2010)
Nucleolar localization of influenza A NS1: striking differences between
mammalian and avian cells. Virol J 7: 63.
20. Keiner B, Maenz B, Wagner R, Cattoli G, Capua I, et al. (2010) Intracellular
distribution of NS1 correlates with infectivity and interferon antagonism of an
avian influenza virus (H7N1). J Virol 84: 11858–11865.
21. Nemeroff ME, Qian XY, Krug RM (1995) The influenza virus NS1 protein
forms multimers in vitro and in vivo. Virology 212: 422–428.
22. Wang X, Basler CF, Williams BR, Silverman RH, Palese P, et al. (2002)
Functional replacement of the carboxy-terminal two-thirds of the influenza A
virus NS1 protein with short heterologous dimerization domains. J Virol 76:
12951–12962.
23. Yin C, Khan JA, Swapna GV, Ertekin A, Krug RM, et al. (2007) Conserved
Surface Features Form the Double-stranded RNA Binding Site of Non-
structural Protein 1 (NS1) from Influenza A and B Viruses. J Biol Chem 282:
20584–20592.
24. Liu J, Lynch PA, Chien CY, Montelione GT, Krug RM, et al. (1997) Crystal
structure of the unique RNA-binding domain of the influenza virus NS1 protein.
Nat Struct Biol 4: 896–899.
25. Cheng A, Wong SM, Yuan YA (2009) Structural basis for dsRNA recognition by
NS1 protein of influenza A virus. Cell Res 19: 187–195.
26. Chien CY, Tejero R, Huang Y, Zimmerman DE, Rios CB, et al. (1997) A novel
RNA-binding motif in influenza A virus non-structural protein 1. Nat Struct Biol
4: 891–895.
27. Bornholdt ZA, Prasad BV (2008) X-ray structure of NS1 from a highly
pathogenic H5N1 influenza virus. Nature 456: 985–988.
28. Hale BG, Barclay WS, Randall RE, Russell RJ (2008) Structure of an avian
influenza A virus NS1 protein effector domain. Virology 378: 1–5.
29. Bornholdt ZA, Prasad BV (2006) X-ray structure of influenza virus NS1 effector
domain. Nat Struct Mol Biol 13: 559–560.
30. Xia S, Monzingo AF, Robertus JD (2009) Structure of NS1A effector domain
from the influenza A/Udorn/72 virus. Acta Crystallogr D Biol Crystallogr 65:
11–17.
31. Xia S, Robertus JD (2010) X-ray structures of NS1 effector domain mutants.
Arch Biochem Biophys 494: 198–204.
32. Hale BG, Kerry PS, Jackson D, Precious BL, Gray A, et al. (2010) Structural
insights into phosphoinositide 3-kinase activation by the influenza A virus NS1
protein. Proc Natl Acad Sci U S A 107: 1954–1959.
33. Das K, Ma LC, Xiao R, Radvansky B, Aramini J, et al. (2008) Structural basis
for suppression of a host antiviral response by influenza A virus. Proc Natl Acad
Sci U S A 105: 13093–13098.
34. Xu Q, Dunbrack RL (2011) The protein common interface database
(ProtCID)—a comprehensive database of interactions of homologous proteins
in multiple crystal forms. Nucl Acids Res 39: D761–770.
35. Donelan NR, Basler CF, Garcia-Sastre A (2003) A recombinant influenza A
virus expressing an RNA-binding-defective NS1 protein induces high levels of
beta interferon and is attenuated in mice. J Virol 77: 13257–13266.
36. Wang W, Riedel K, Lynch P, Chien CY, Montelione GT, et al. (1999) RNA
binding by the novel helical domain of the influenza virus NS1 protein requires
its dimer structure and a small number of specific basic amino acids. RNA 5:
195–205.
37. Qian XY, Chien CY, Lu Y, Montelione GT, Krug RM (1995) An amino-
terminal polypeptide fragment of the influenza virus NS1 protein possesses
specific RNA-binding activity and largely helical backbone structure. RNA 1:
948–956.
38. Russ WP, Engelman DM (2000) The GxxxG motif: a framework for
transmembrane helix-helix association. J Mol Biol 296: 911–919.
39. Senes A, Engel DE, DeGrado WF (2004) Folding of helical membrane proteins:
the role of polar, GxxxG-like and proline motifs. Curr Opin Struct Biol 14:
465–479.
40. Miknis ZJ, Donaldson EF, Umland TC, Rimmer RA, Baric RS, et al. (2009)
Severe acute respiratory syndrome coronavirus nsp9 dimerization is essential for
efficient viral growth. J Virol 83: 3007–3018.
41. Bahadur RP, Chakrabarti P, Rodier F, Janin J (2003) Dissecting subunit
interfaces in homodimeric proteins. Proteins 53: 708–719.
42. Dey S, Pal A, Chakrabarti P, Janin J (2010) The subunit interfaces of weakly
associated homodimeric proteins. J Mol Biol 398: 146–160.
43. Nooren IM, Thornton JM (2003) Structural characterisation and functional
significance of transient protein-protein interactions. J Mol Biol 325: 991–1018.
44. Janin J, Bahadur RP, Chakrabarti P (2008) Protein-protein interaction and
quaternary structure. Q Rev Biophys 41: 133–180.
45. Steidle S, Martinez-Sobrido L, Mordstein M, Lienenklaus S, Garcia-Sastre A,
et al. (2010) Glycine 184 in the non-structural protein NS1 determines virulence
Influenza Virus NS1 Multimerization
PLoS ONE | www.plosone.org 12 March 2011 | Volume 6 | Issue 3 | e17946
of influenza A virus strain PR8 without affecting the host interferon response.
J Virol 84: 12761–12770.
46. Perkins JR, Diboun I, Dessailly BH, Lees JG, Orengo C (2010) Transient
protein-protein interactions: structural, functional, and network properties.
Structure 18: 1233–1243.
47. Otwinowski Z, Minor W (1993) In: Sawyer L, Isaacs N, Bailey S, eds. Data
Collection and Processing Warrington: SERC Daresbury Laboratory. pp
556–562.
48. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, et al.
(2007) Phaser crystallographic software. J Appl Crystallogr 40: 658–674.
49. CCP4 (1994) The CCP4 suite: programs for protein crystallography. Acta
Crystallogr D Biol Crystallogr 50: 760–763.
50. Adams PD, Grosse-Kunstleve RW, Hung LW, Ioerger TR, McCoy AJ, et al.
(2002) PHENIX: building new software for automated crystallographic structure
determination. Acta Crystallogr D Biol Crystallogr 58: 1948–1954.
51. Jones TA, Zou JY, Cowan SW, Kjeldgaard M (1991) Improved methods for
building protein models in electron density maps and the location of errors in
these models. Acta Crystallogr A 47(Pt 2): 110–119.
52. Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics.
Acta Crystallogr D Biol Crystallogr 60: 2126–2132.
53. Schrodinger, LLC (2010) The PyMOL Molecular Graphics System, Version
1.3r1.
54. Reynolds C, Damerell D, Jones S (2009) ProtorP: a protein-protein interaction
analysis server. Bioinformatics 25: 413–414.
55. Saha RP, Bahadur RP, Pal A, Mandal S, Chakrabarti P (2006) ProFace: a server
for the analysis of the physicochemical features of protein-protein interfaces.
BMC Struct Biol 6: 11.
56. Niwa H, Yamamura K, Miyazaki J (1991) Efficient selection for high-expression
transfectants with a novel eukaryotic vector. Gene 108: 193–199.
57. Yoneyama M, Suhara W, Fukuhara Y, Fukuda M, Nishida E, et al. (1998)
Direct triggering of the type I interferon system by virus infection: activation of a
transcription factor complex containing IRF-3 and CBP/p300. EMBO J 17:
1087–1095.
58. Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image Processing with ImageJ.
Biophotonics International 11: 36–42.
Influenza Virus NS1 Multimerization
PLoS ONE | www.plosone.org 13 March 2011 | Volume 6 | Issue 3 | e17946
